HAS-BLED Score for Major Bleeding Risk

If high risk for bleeding: regular check-ups after start of oral anticoagulation

The HAS-BLED Score estimates 1‑year major bleeding risk in anticoagulated patients with atrial fibrillation 1.

History of Hypertension?
No0Yes+1
Renal Disease?
No0Yes+1
Liver Disease?
No0Yes+1
History of Stroke?
No0Yes+1
Prior Major Bleeding/Predisposed to bleeding?
No0Yes+1
Labile INR?
No0Yes+1
Older than 65 years old?
No0Yes+1
Medications that predispose to bleeding?
No0Yes+1
History of alcohol or drug usage?
No0Yes+1

使用適応

Used in adults with atrial fibrillation being considered for oral anticoagulation to flag high bleeding risk and guide modification of reversible factors—not to withhold therapy. Identifies hypertension, renal/hepatic dysfunction, prior stroke, prior bleeding, labile INR, age >65, and drugs/alcohol as risks (ACC/AHA 2023 AF Guideline 1 [Level I evidence]). Predicts major bleeding with modest discrimination and performs better than CHADS2/CHA2DS2‑VASc for bleeding (JACC 2013 2 [Level II evidence]).

洞察と注意事項

Identifies modifiable bleeding risks but should not guide anticoagulation decisions alone because predictive ability is only modest (c‑index ~0.58–0.59) per the 2023 ACC/AHA AF guideline 1 [Level I evidence]. High scores prompt correction of reversible factors (e.g., BP, NSAIDs, alcohol). External validations show balanced but limited discrimination 2 [Level II evidence]. A high score is not a reason to withhold OAC.